Medical device and MedTech insights, news, tips and more

Medical Errors, the 3rd Leading Cause of Death in the US

July 18, 2016

Medical Errors

Recently, a study by Johns Hopkins made headlines by claiming that medical errors are now the third leading cause of death in the US. While that startling statistic was later challenged as being overly broad, it’s clear that over 100,000 people die in the US every year from preventable medical errors.

 

Medical Errors

Robert Kaul – President and Chief Executive Officer Cloud DX Incorporated

The US Government reports that every single day, around 10,000 Americans turn 65 and qualify for Medicare. If current Medicare spending trends continue unchanged, according to the US Social Security Advisory Board, healthcare spending will consume the majority of the federal budget by 2030, leaving little room for any other functions of Government.

The so-called “Silver Tsunami” of retiring baby-boomers not only puts enormous economic stress on our current healthcare system, it also raises the demand for support services. A looming shortage of doctors as well as personal home healthcare workers has generated anxiety in the industry. The only obvious solution is to deploy technology to help care for older adults, whose chronic conditions consume over 33% of all healthcare dollars.

Now imagine a world where medical errors were a thing of the past, and every person has the option of growing old at home in safety and dignity… all due to the dawn of medical Artificial Intelligence (AI).

Simply put, medical AI enables computers to help interpret healthcare data by recognizing patterns, providing insights to physicians to make better treatment decisions for patients. In the past healthcare progress relied on the discovery of new medications, vaccines and surgical procedures. Since the turn of the 21st century, the pace of these advances has slowed, and the growth of digital healthcare has taken off.

 

Read Full Article – Source: Medical Technologies: Leveraging Medical Artificial Intelligence to Meet the “Silver Tsunami” of Healthcare

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.